LASAPharmaceuticals
Lassonde Industries Inc — Cash Flow Statement
₹5.67
-12.87%
Lassonde Industries Inc Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Investing Cash Flow | 8.15 Cr | -0.39 Cr | 11.19 Cr | -2.91 Cr | — |
| Net Other Investing Changes | 1000.00 | -2.32 Cr | — | 1000.00 | -1000.00 |
| Interest Received Cfi | 0.01 Cr | 0.18 Cr | 1.80 Cr | 0.10 Cr | — |
| Net Investment Purchase And Sale | 0.37 Cr | 1.09 Cr | 4.56 Cr | -5.59 Cr | — |
| Net PPE Purchase And Sale | 7.76 Cr | -1.66 Cr | 4.83 Cr | 2.58 Cr | — |
| Sale Of PPE | 7.76 Cr | 0.66 Cr | 4.83 Cr | 2.58 Cr | — |
| Operating Cash Flow | -2.82 Cr | 1.83 Cr | -17.30 Cr | 9.21 Cr | — |
| Taxes Refund Paid | 0.00 | 0.00 | -0.04 Cr | -2.59 Cr | — |
| Change In Working Capital | -11.98 Cr | -0.37 Cr | 9.18 Cr | 3.59 Cr | — |
| Change In Other Current Liabilities | 3.36 Cr | 0.09 Cr | 0.32 Cr | -6.82 Cr | — |
| Change In Other Current Assets | 1.64 Cr | 6.62 Cr | -1.42 Cr | 3.57 Cr | — |
| Change In Payable | -3.84 Cr | 4.63 Cr | -7.48 Cr | 3.21 Cr | — |
| Change In Inventory | -5.45 Cr | -5.14 Cr | -2.41 Cr | 5.76 Cr | — |
| Change In Receivables | 2.10 Cr | -7.56 Cr | 16.07 Cr | -3.75 Cr | — |
| Other Non Cash Items | 9.69 Cr | 4.08 Cr | -17.54 Cr | -8.09 Cr | — |
| Provisionand Write Offof Assets | 6.45 Cr | 6.45 Cr | 0.00 | 0.00 | — |
| Depreciation And Amortization | 12.30 Cr | 10.67 Cr | 13.42 Cr | 14.51 Cr | — |
| Depreciation | 12.30 Cr | 10.67 Cr | 11.98 Cr | 14.51 Cr | — |
| Pension And Employee Benefit Expense | 0.04 Cr | 0.12 Cr | 0.05 Cr | 0.08 Cr | — |
| Gain Loss On Sale Of PPE | 0.06 Cr | 0.00 | — | — | — |
| Net Income From Continuing Operations | -19.38 Cr | -19.11 Cr | -22.37 Cr | 1.72 Cr | — |
| Free Cash Flow | -2.82 Cr | 0.17 Cr | -17.30 Cr | 9.21 Cr | — |
| Issuance Of Capital Stock | 1.75 Cr | 0.00 | — | 0.00 | 0.00 |
| End Cash Position | 0.28 Cr | 0.61 Cr | 0.80 Cr | 11.07 Cr | — |
| Beginning Cash Position | 0.61 Cr | 0.80 Cr | 11.07 Cr | 4.81 Cr | — |
| Changes In Cash | -0.33 Cr | -0.19 Cr | -10.27 Cr | 6.26 Cr | — |
| Financing Cash Flow | -5.66 Cr | -1.63 Cr | -4.16 Cr | -0.04 Cr | — |
| Net Other Financing Charges | 0.53 Cr | — | — | — | — |
| Interest Paid Cff | -2.69 Cr | -1.93 Cr | -4.16 Cr | -0.04 Cr | — |
| Net Common Stock Issuance | 1.75 Cr | 0.00 | — | 0.00 | 0.00 |
| Common Stock Issuance | 1.75 Cr | 0.00 | — | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -5.25 Cr | 0.31 Cr | — | 0.00 | -34.48 Cr |
| Net Short Term Debt Issuance | -5.25 Cr | 0.31 Cr | — | 0.00 | -20.34 Cr |
| Purchase Of PPE | — | -1.66 Cr | — | — | -6.59 Cr |
| Capital Expenditure | — | -1.66 Cr | — | — | -6.59 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | — | — | -1000.00 |
| Amortization Cash Flow | — | — | 1.44 Cr | — | — |
| Short Term Debt Issuance | — | — | — | 0.00 | — |
| Net Long Term Debt Issuance | — | — | — | 0.00 | -14.14 Cr |
| Long Term Debt Payments | — | — | — | 0.00 | -14.14 Cr |
| Long Term Debt Issuance | — | — | — | 0.00 | — |
| Repayment Of Debt | — | — | — | 0.00 | -34.48 Cr |
| Issuance Of Debt | — | — | — | 0.00 | — |
| Short Term Debt Payments | — | — | — | 0.00 | -20.34 Cr |
| Capital Expenditure Reported | — | — | — | — | -6.59 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Lassonde Industries Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.